Sotera Health Company (SHC) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 11 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for SHC is $22.67, representing a +42.3% upside from the current price of $15.93. Price targets range from a low of $20.00 to a high of $24.00.
